News
Investor's Business Daily on MSN12h
Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of EuropeSarepta Therapeutics' brutal week continued Friday after European officials rejected the company's controversial gene therapy ...
Sarepta faces FDA scrutiny over Elevidys as analysts downgrade stock and warn of long-term debt risks amid market uncertainty.
Sarepta Therapeutics, Inc. faces setbacks with Elevidys, safety issues, and workforce cuts, raising concerns about its ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Shares of Sarepta Therapeutics plummeted Friday following a report that a third patient has died during a clinical trial for ...
Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price. Read why I am reiterating my bullish rating on ARWR stock.
Detailed price information for Alpha Teknova Inc (TKNO-Q) from The Globe and Mail including charting and trades.
Shares of SRPT stock opened at $21.56 on Monday. The stock has a market cap of $2.12 billion, a price-to-earnings ratio of -8.01 and a beta of 0.61. The firm’s 50 day moving average price is $45 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback